Agios Pharmaceuticals, Inc. (AGIO) Ownership & Trading Activity

Institutional holders, insider transactions, and congressional trades for AGIO. 13F holdings as of 2026-09-30.

In 13F filings for the quarter ended September 30, 2026, 173 institutions reported holding AGIO, with 37.9 million shares worth $1.3 billion in aggregate.

Top Institutional Holders

InstitutionSharesValueChange
BlackRock6,229,199$207MDECREASED
Vanguard6,032,169$201MDECREASED
Morgan Stanley3,436,589$114MINCREASED
State Street3,264,652$109MDECREASED
Assenagon Asset Management1,886,412$63MINCREASED

Recent Insider Trades

InsiderTypeSharesValueDate
Sarah Gheuens (Chief Medical Officer)EXERCISE7,866$197K2026-10-26
Sarah Gheuens (Chief Medical Officer)SELL7,866$296K2026-10-26
Sarah Gheuens (Chief Medical Officer)EXERCISE7,866$197K2026-10-26
Sarah Gheuens (Chief Medical Officer)EXERCISE500$13K2026-10-22
Sarah Gheuens (Chief Medical Officer)SELL500$19K2026-10-22

Recent Congressional Trades

MemberTypeAmountDate
Gilbert Cisneros (Democrat)PURCHASE$1,001 - $15,0002026-08-20

Full institutional holdings, insider history, and congressional trades for Agios Pharmaceuticals, Inc. on SentiSense.